Tumors of the Bile Ducts, Gallbladder, and Ampulla

Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and Print

Volumn , Issue , 2010, Pages 1171-1184

  Blechacz, Boris ^a   Gores, Gregory J ^a,b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85124867482     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6189-2.00069-X     Document Type: Chapter

References (146)

1. Blechacz B., Gores GJ Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment Hepatology 48 2008 308-321(Ref 2.)
2. Buckles DC., Lindor KD., Larusso NF., et al. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant Am J Gastroenterol 97 2002 1138-1142(Ref 50.)
3. Csendes A., Becerra M., Rojas J., Medina E Number and size of stones in patients with asymptomatic and symptomatic gallstones and gallbladder carcinoma: A prospective study of 592 cases J Gastrointest Surg 4 2000 481-485(Ref 45.)
4. Gores GJ., Nagorney DM., Rosen CB Cholangiocarcinoma: Is transplantation an option? For whom? J Hepatol 47 2007 455-459(Ref 35.)
5. Isomoto H., Kobayashi S., Werneburg NW., et al. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells Hepatology 42 2005 1329-1338(Ref 16.)
6. Ito H., Matros E., Brooks DC., et al. Treatment outcomes associated with surgery for gallbladder cancer: A 20-year experience J Gastrointest Surg 8 2004 183-190(Ref 70.)
7. Jaiswal M., LaRusso NF., Burgart LJ., Gores GJ Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res 60 2000 184-190(Ref 15.)
8. Kimura W., Futakawa N., Yamagata S., et al. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater Jpn J Cancer Res 85 1994 161-166(Ref 86.)
9. Levy C., Lymp J., Angulo P., et al. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis Dig Dis Sci 50 2005 1734-1740(Ref 23.)
10. Moreno Luna LE., Kipp B., Halling KC., et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures Gastroenterology 131 2006 1064-1072(Ref 27.)
11. O’Connell JB., Maggard MA., Manunga J., et al. Survival after resection of ampullary carcinoma: A national population-based study Ann Surg Oncol 15 2008 1820-1827(Ref 76.)
12. Petrowsky H., Wildbrett P., Husarik DB., et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma J Hepatol 45 2006 43-50(Ref 26.)
13. van der Gaag NA., ten Kate FJ., Lagarde SM., et al. Prognostic significance of extracapsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater Br J Surg 95 2008 735-743(Ref 94.)
14. Yoon JH., Canbay AE., Werneburg NW., et al. Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: Implications for biliary tract carcinogenesis Hepatology 39 2004 732-738(Ref 19.)
15. Yoon JH., Gwak GY., Lee HS., et al. Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells J Hepatol 41 2004 808-814(Ref 18.)
16. Kondo S., Takada T., Miyazaki M., et al. Guidelines for the management of biliary tract and ampullary carcinomas: Surgical treatment J Hepatobiliary Pancreat Surg 15 2008 41-54.
17. Blechacz B., Gores GJ Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment Hepatology 48 2008 308-321.
18. Welzel TM., McGlynn KA., Hsing AW., et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra-and extrahepatic cholangiocarcinoma in the United States J Natl Cancer Inst 98 2006 873-875.
19. Farley DR., Weaver AL., Nagorney DM “Natural history” of unresected cholangiocarcinoma: Patient outcome after noncurative intervention Mayo Clin Proc 70 1995 425-429.
20. Shaib Y., El-Serag HB The epidemiology of cholangiocarcinoma Semin Liver Dis 24 2004 115-125.
21. Burak K., Angulo P., Pasha TM., et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis Am J Gastroenterol 99 2004 523-526.
22. Watanapa P., Watanapa WB Liver fluke-associated cholangiocarcinoma Br J Surg 89 2002 962-970.
23. Chapman RW Risk factors for biliary tract carcinogenesis Ann Oncol 10 Suppl 4 1999 308-311.
24. Lesurtel M., Regimbeau JM., Farges O., et al. Intrahepatic cholangiocarcinoma and hepatolithiasis: An unusual association in Western countries Eur J Gastroenterol Hepatol 14 2002 1025-1027.
25. Tocchi A., Mazzoni G., Liotta G., et al. Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: A follow-up study of more than 1, 000 patients Ann Surg 234 2001 210-214.
26. Walker NJ., Crockett PW., Nyska A., et al. Dose-additive carcinogenicity of a defined mixture of “dioxin-like compounds.” Environ Health Perspect 113 2005 43-48.
27. Blechacz BR., Gores GJ Cholangiocarcinoma Clin Liver Dis 12 2008 131-150.
28. Lim JH., Park CK Pathology of cholangiocarcinoma Abdom Imaging 29 2004 540-547.
29. Nomoto K., Tsuneyama K., Cheng C., et al. Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype Pathol Res Pract 202 2006 71-76.
30. Jaiswal M., LaRusso NF., Burgart LJ., Gores GJ Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res 60 2000 184-190.
31. Isomoto H., Kobayashi S., Werneburg NW., et al. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells Hepatology 42 2005 1329-1338.
32. Kobayashi S., Werneburg NW., Bronk SF., et al. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells Gastroenterology 128 2005 2054-2065.
33. Yoon JH., Gwak GY., Lee HS., et al. Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells J Hepatol 41 2004 808-814.
34. Yoon JH., Canbay AE., Werneburg NW., et al. Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: Implications for biliary tract carcinogenesis Hepatology 39 2004 732-738.
35. Yoon JH., Higuchi H., Werneburg NW., et al. Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line Gastroenterology 122 2002 985-993.
36. Lai GH., Radaeva S., Nakamura T., Sirica AE Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated “intestinal-type” biliary cancer chemically induced in rat liver Hepatology 31 2000 1257-1265.
37. Chen CY., Shiesh SC., Tsao HC., Lin XZ The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma-the influence of sampling time and hepatolithiasis Hepatogastroenterology 49 2002 616-620.
38. Levy C., Lymp J., Angulo P., et al. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis Dig Dis Sci 50 2005 1734-1740.
39. Patel AH., Harnois DM., Klee GG., et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis Am J Gastroenterol 95 2000 204-207.
40. Raman SS., Lu DS., Chen SC., et al. Hepatic MR imaging using ferumoxides: Prospective evaluation with surgical and intraoperative sonographic confirmation in 25 cases AJR Am J Roentgenol 177 2001 807-812.
41. Petrowsky H., Wildbrett P., Husarik DB., et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma J Hepatol 45 2006 43-50.
42. Moreno Luna LE., Kipp B., Halling KC., et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures Gastroenterology 131 2006 1064-1072.
43. In: Greene FL., Page DL., Fleming ID AJCC Cancer Staging Manual6th ed 2002 Springer New York 421.
44. Jarnagin WR., Fong Y., DeMatteo RP., et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234 2001 507-517.
45. Nathan H., Pawlik TM., Wolfgang CL., et al. Trends in survival after surgery for cholangiocarcinoma: A 30-year population-based SEER database analysis J Gastrointest Surg 11 2007 1488-1496.
46. Weimann A., Varnholt H., Schlitt HJ., et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma Br J Surg 87 2000 1182-1187.
47. Nagorney DM., Kendrick ML Hepatic resection in the treatment of hilar cholangiocarcinoma Adv Surg 40 2006 159-171.
48. Abdalla EK., Barnett CC., Doherty D., et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization Arch Surg 137 2002 675-680.
49. Meyer CG., Penn I., James L Liver transplantation for cholangiocarcinoma: Results in 207 patients Transplantation 69 2000 1633-1637.
50. Gores GJ., Nagorney DM., Rosen CB Cholangiocarcinoma: Is transplantation an option? For whom? J Hepatol 47 2007 455-459.
51. Smith AC., Dowsett JF., Russell RC., et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction Lancet 344 1994 1655-1660.
52. Weston BR., Ross WA., Wolff RA., et al. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: How soon should we repeat endoscopic retrograde cholangiopancreatography? Cancer 112 2008 2417-2423.
53. Shim CS., Cheon YK., Cha SW., et al. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment Endoscopy 37 2005 425-433.
54. Zoepf T., Jakobs R., Arnold JC., et al. Palliation of nonresectable bile duct cancer: Improved survival after photodynamic therapy Am J Gastroenterol 100 2005 2426-2430.
55. Sheth S., Bedford A., Chopra S Primary gallbladder cancer: Recognition of risk factors and the role of prophylactic cholecystectomy Am J Gastroenterol 95 2000 1402-1410.
56. Randi G., Franceschi S., La Vecchia C Gallbladder cancer worldwide: Geographical distribution and risk factors Int J Cancer 118 2006 1591-1602.
57. Lazcano-Ponce EC., Miquel JF., Munoz N., et al. Epidemiology and molecular pathology of gallbladder cancer CA Cancer J Clin 51 2001 349-364.
58. Maringhini A., Moreau JA., Melton LJ 3rd., et al. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota Ann Intern Med 107 1987 30-35.
59. Nervi F., Duarte I., Gomez G., et al. Frequency of gallbladder cancer in Chile, a high-risk area Int J Cancer 41 1988 657-660.
60. Csendes A., Becerra M., Rojas J., Medina E Number and size of stones in patients with asymptomatic and symptomatic gallstones and gallbladder carcinoma: A prospective study of 592 cases J Gastrointest Surg 4 2000 481-485.
61. Miyazaki M., Takada T., Miyakawa S., et al. Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors J Hepatobiliary Pancreat Surg 15 2008 15-24.
62. Stephen AE., Berger DL Carcinoma in the porcelain gallbladder: A relationship revisited Surgery 129 2001 699-703.
63. Myers RP., Shaffer EA., Beck PL Gallbladder polyps: Epidemiology, natural history and management Can J Gastroenterol 16 2002 187-194.
64. Funabiki T., Matsubara T., Miyakawa S., Ishihara S Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy Langenbecks Arch Surg 394 2009 159-169.
65. Buckles DC., Lindor KD., Larusso NF., et al. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant Am J Gastroenterol 97 2002 1138-1142.
66. Lewis JT., Talwalkar JA., Rosen CB., et al. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: Evidence for a metaplasia-dysplasia-carcinoma sequence Am J Surg Pathol 31 2007 907-913.
67. Nabatame N., Shirai Y., Nishimura A., et al. High risk of gallbladder carcinoma in elderly patients with segmental adenomyomatosis of the gallbladder J Exp Clin Cancer Res 23 2004 593-598.
68. Shukla VK., Singh H., Pandey M., et al. Carcinoma of the gallbladder-is it a sequel of typhoid? Dig Dis Sci 45 2000 900-903.
69. Fernandez E., La Vecchia C., D’Avanzo B., et al. Family history and the risk of liver, gallbladder, and pancreatic cancer Cancer Epidemiol Biomarkers Prev 3 1994 209-212.
70. Misra S., Chaturvedi A., Misra NC., Sharma ID Carcinoma of the gallbladder Lancet Oncol 4 2003 167-176.
71. Reid KM., Ramos-De la Medina A., Donohue JH Diagnosis and surgical management of gallbladder cancer: A review J Gastrointest Surg 11 2007 671-681.
72. Gore RM., Shelhamer RP Biliary tract neoplasms: Diagnosis and staging Cancer Imaging 7 Spec No A 2007 S15-S23.
73. Roa I., de Aretxabala X., Araya JC., Roa J Preneoplastic lesions in gallbladder cancer J Surg Oncol 93 2006 615-623.
74. Roa I., Araya JC., Villaseca M., et al. Preneoplastic lesions and gallbladder cancer: An estimate of the period required for progression Gastroenterology 111 1996 232-236.
75. Wee A., Teh M., Raju GC Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions J Clin Pathol 47 1994 453-456.
76. Fujii K., Yokozaki H., Yasui W., et al. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder Cancer Epidemiol Biomarkers Prev 5 1996 461-466.
77. Sasatomi E., Tokunaga O., Miyazaki K Precancerous conditions of gallbladder carcinoma: Overview of histopathologic characteristics and molecular genetic findings J Hepatobiliary Pancreat Surg 7 2000 556-567.
78. Fujii K., Yasui W., Shimamoto F., et al. Immunohistochemical analysis of nm23 gene product in human gallbladder carcinomas Virchows Arch 426 1995 355-359.
79. Kim YW., Huh SH., Park YK., et al. Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas Oncol Rep 8 2001 1127-1132.
80. Lynch BC., Lathrop SL., Ye D., et al. Expression of the p16(INK4a) gene product in premalignant and malignant epithelial lesions of the gallbladder Ann Diagn Pathol 12 2008 161-164.
81. Yoshida T., Sugai T., Habano W., et al. Microsatellite instability in gallbladder carcinoma: Two independent genetic pathways of gallbladder carcinogenesis J Gastroenterol 35 2000 768-774.
82. Hirooka Y., Naitoh Y., Goto H., et al. Differential diagnosis of gall-bladder masses using colour Doppler ultrasonography J Gastroenterol Hepatol 11 1996 840-846.
83. Anderson CD., Rice MH., Pinson CW., et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma J Gastrointest Surg 8 2004 90-97.
84. Koh T., Taniguchi H., Yamaguchi A., et al. Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET) J Surg Oncol 84 2003 74-81.
85. Ito H., Matros E., Brooks DC., et al. Treatment outcomes associated with surgery for gallbladder cancer: A 20-year experience J Gastrointest Surg 8 2004 183-190.
86. Wakai T., Shirai Y., Yokoyama N., et al. Early gallbladder carcinoma does not warrant radical resection Br J Surg 88 2001 675-678.
87. You DD., Lee HG., Paik KY., et al. What is an adequate extent of resection for T1 gallbladder cancers? Ann Surg 247 2008 835-838.
88. Mekeel KL., Hemming AW Surgical management of gallbladder carcinoma: A review J Gastrointest Surg 11 2007 1188-1193.
89. Miller G., Jarnagin WR Gallbladder carcinoma Eur J Surg Oncol 34 2008 306-312.
90. Paolucci V., Schaeff B., Schneider M., Gutt C Tumor seeding following laparoscopy: International survey World J Surg 23 1999 989-995.
91. O’Connell JB., Maggard MA., Manunga J., et al. Survival after resection of ampullary carcinoma: A national population-based study Ann Surg Oncol 15 2008 1820-1827.
92. Fischer HP., Zhou H Pathogenesis of carcinoma of the papilla of Vater J Hepatobiliary Pancreat Surg 11 2004 301-309.
93. Offerhaus GJ., Giardiello FM., Krush AJ., et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis Gastroenterology 102 1992 1980-1982.
94. Mao C., Huang Y., Howard JM Carcinoma of the ampulla of Vater and mesenteric fibromatosis (desmoid tumor) associated with Gardner’s syndrome: Problems in management Pancreas 10 1995 239-245.
95. Jarvinen HJ., Aarnio M., Mustonen H., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer Gastroenterology 118 2000 829-834.
96. Costi R., Caruana P., Sarli L., et al. Ampullary adenocarcinoma in neurofibromatosis type 1. Case report and literature review Mod Pathol 14 2001 1169-1174.
97. Matthews JJ., Roberts R., O’Reilly DA., et al. Muir-Torre syndrome: A case for surveillance of the ampulla of Vater Dig Surg 19 2002 65-66.
98. Kimura W., Ohtsubo K Incidence, sites of origin, and immunohistochemical and histochemical characteristics of atypical epithelium and minute carcinoma of the papilla of Vater Cancer 61 1988 1394-1402.
99. Schirmacher P., Buchler MW Ampullary adenocarcinoma-differentiation matters BMC Cancer 8 2008 251.
100. Carter JT., Grenert JP., Rubenstein L., et al. Tumors of the ampulla of Vater: Histopathologic classification and predictors of survival J Am Coll Surg 207 2008 210-218.
101. Kimura W., Futakawa N., Yamagata S., et al. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater Jpn J Cancer Res 85 1994 161-166.
102. Zhou H., Schaefer N., Wolff M., Fischer HP Carcinoma of the ampulla of Vater: Comparative histologic/immunohistochemical classification and follow-up Am J Surg Pathol 28 2004 875-882.
103. Zhao B., Kimura W., Futakawa N., et al. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater Am J Gastroenterol 94 1999 2128-2134.
104. Li X., Hui AM., Shi YZ., et al. Deregulation of G1/S transition is a common event in carcinoma of the ampulla of Vater Hepatogastroenterology 49 2002 1239-1244.
105. Kamisawa T., Fukayama M., Koike M., et al. Carcinoma of the ampulla of Vater: Expression of cancer-associated antigens inversely correlated with prognosis Am J Gastroenterol 83 1988 1118-1123.
106. Kim JH., Kim MJ., Chung JJ., et al. Differential diagnosis of periampullary carcinomas at MR imaging Radiographics 22 2002 1335-1352.
107. Puli SR., Singh S., Hagedorn CH., et al. Diagnostic accuracy of EUS for vascular invasion in pancreatic and periampullary cancers: A meta-analysis and systematic review Gastrointest Endosc 65 2007 788-797.
108. Tio TL., Sie LH., Kallimanis G., et al. Staging of ampullary and pancreatic carcinoma: Comparison between endosonography and surgery Gastrointest Endosc 44 1996 706-713.
109. van der Gaag NA., ten Kate FJ., Lagarde SM., et al. Prognostic significance of extracapsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater Br J Surg 95 2008 735-743.
110. Talamini MA., Moesinger RC., Pitt HA., et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience Ann Surg 225 1997 590-599.
111. Bucher P., Chassot G., Durmishi Y., et al. Long-term results of surgical treatment of Vater’s ampulla neoplasms Hepatogastroenterology 54 2007 1239-1242.
112. Brown KM., Tompkins AJ., Yong S., et al. Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer Arch Surg 140 2005 529-532.
113. Bogoevski D., Chayeb H., Cataldegirmen G., et al. Nodal microinvolvement in patients with carcinoma of the papilla of Vater receiving no adjuvant chemotherapy J Gastrointest Surg 2008.
114. Krishnan S., Rana V., Evans DB., et al. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of Vater Int J Radiat Oncol Biol Phys 70 2008 735-743.
115. Mehta VK., Fisher GA., Ford JM., et al. Adjuvant chemoradiotherapy for “unfavorable” carcinoma of the ampulla of Vater: Preliminary report Arch Surg 136 2001 65-69.
116. Caceres M., Mosquera LF., Shih JA., O’Leary JP Paraganglioma of the bile duct South Med J 94 2001 515-518.
117. Kumar S., Agarwal S., Bhargava SK., Minocha VR Malignant carcinoid tumor of the gallbladder: A case report and review of literature Trop Gastroenterol 13 1992 78-84.
118. Yokoyama Y., Fujioka S., Kato K., et al. Primary carcinoid tumor of the gallbladder: Resection of a case metastasizing to the liver and analysis of outcomes Hepatogastroenterology 47 2000 135-139.
119. Ferrone CR., Tang LH., D’Angelica M., et al. Extrahepatic bile duct carcinoid tumors: Malignant biliary obstruction with a good prognosis J Am Coll Surg 205 2007 357-361.
120. Gusani NJ., Marsh JW., Nalesnik MA., et al. Carcinoid of the extra-hepatic bile duct: A case report with long-term follow-up and review of literature Am Surg 74 2008 87-90.
121. Jimenez R., Beguiristain A., Ruiz-Montesinos I., et al. Intrahepatic biliary carcinoid Am J Clin Oncol 31 2008 521-522.
122. Bucher P., Mathe Z., Buhler L., et al. Paraganglioma of the ampulla of Vater: A potentially malignant neoplasm Scand J Gastroenterol 39 2004 291-295.
123. Lochan R., Balupuri S., Bennett MK., Manas DM Granular cell tumor as an unusual cause of obstruction at the hepatic hilum: Report of a case Surg Today 36 2006 934-936.
124. Hoda RS., Minamiguchi S., Lewin DN., et al. Granular cell tumor of the biliary system: A report of 2 cases with cytologic diagnosis on endoscopic brushing Acta Cytol 49 2005 199-203.
125. Wysocki A., Papla B., Budzynski P Neuromas of the extrahepatic bile ducts as a cause of obstructive jaundice Eur J Gastroenterol Hepatol 14 2002 573-576.
126. Choi JY., Kim MJ., Chung JJ., et al. Gallbladder lymphangioma: MR findings Abdom Imaging 27 2002 54-57.
127. Kim JK., Yoo KS., Moon JH., et al. Gallbladder lymphangioma: A case report and review of the literature World J Gastroenterol 13 2007 320-323.
128. Yang HR., Jan YY., Huang SF., et al. Laparoscopic cholecystectomy for gallbladder lymphangiomas Surg Endosc 17 2003 1676.
129. Artaza T., Potenciano JM., Legaz M., et al. Lymphangioma of Vater’s ampulla: A rare cause of obstructive jaundice. Endoscopic therapy Scand J Gastroenterol 30 1995 804-806.
130. Sriram PV., Weise C., Seitz U., et al. Lymphangioma of the major duodenal papilla presenting as acute pancreatitis: Treatment by endoscopic snare papillectomy Gastrointest Endosc 51 2000 733-736.
131. Chahal P., Prasad GA., Sanderson SO., et al. Endoscopic resection of nonadenomatous ampullary neoplasms J Clin Gastroenterol 41 2007 661-666.
132. Boyle L., Gallivan MV., Chun B., Lack EE Heterotopia of gastric mucosa and liver involving the gallbladder. Report of two cases with literature review Arch Pathol Lab Med 116 1992 138-142.
133. Hamazaki K., Fujiwara T Heterotopic gastric mucosa in the gallbladder J Gastroenterol 35 2000 376-381.
134. Delis S., Triantopoulou C., Kyzas PA., Dervenis C Multiple primary liver lipomas in a patient with chronic hepatitis B: A case report Eur J Gastroenterol Hepatol 19 2007 807-809.
135. Yu FC., Chen JH., Yang KC., Wu CC., Chou YY Hepatobiliary cystadenoma: A report of two cases J Gastrointestin Liver Dis 17 2008 203-206.
136. Vogt DP., Henderson JM., Chmielewski E Cystadenoma and cystadenocarcinoma of the liver: A single center experience J Am Coll Surg 200 2005 727-733.
137. Devaney K., Goodman ZD., Ishak KG Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients Am J Surg Pathol 18 1994 1078-1091.
138. Waldmann J., Zielke A., Moll R., et al. Cystadenocarcinoma of the gallbladder J Hepatobiliary Pancreat Surg 13 2006 594-599.
139. Bejarano Gonzalez N., Garcia Moforte N., Darnell Martin A., et al. Primary malignant melanoma of the common bile duct: A case report and literature review Gastroenterol Hepatol 28 2005 382-384.
140. Garas G., Bramston B., Edmunds SE Malignant melanoma metastatic to the common bile duct J Gastroenterol Hepatol 15 2000 1348-1351.
141. Eliason SC., Grosso LE Primary biliary malignant lymphoma clinically mimicking cholangiocarcinoma: A case report and review of the literature Ann Diagn Pathol 5 2001 25-33.
142. Sugawara G., Nagino M., Oda K., et al. Follicular lymphoma of the extrahepatic bile duct mimicking cholangiocarcinoma J Hepatobiliary Pancreat Surg 15 2008 196-199.
143. Zampieri N., Camoglio F., Corroppolo M., et al. Botryoid rhabdomyosarcoma of the biliary tract in children: A unique case report Eur J Cancer Care (Engl) 15 2006 463-466.
144. Sanz N., de Mingo L., Florez F., Rollan VV Rhabdomyosarcoma of the biliary tree Pediatr Surg Int 12 1997 200-201.
145. Spunt SL., Lobe TE., Pappo AS., et al. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma J Pediatr Surg 35 2000 309-316.
146. Ferluga D., Luzar B., Gadzijev EM Follicular lymphoma of the gallbladder and extrahepatic bile ducts Virchows Arch 442 2003 136-140.